| Year |
Citation |
Score |
| 2019 |
Luo J, Wang K, Yeh S, Sun Y, Liang L, Xiao Y, Xu W, Niu Y, Cheng L, Maity SN, Jiang R, Chang C. LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling. Nature Communications. 10: 2571. PMID 31189930 DOI: 10.1038/S41467-019-09784-9 |
0.387 |
|
| 2018 |
Soundararajan R, Paranjape AN, Maity S, Aparicio A, Mani SA. EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancers. Biochimica Et Biophysica Acta. PMID 29981816 DOI: 10.1016/J.Bbcan.2018.06.006 |
0.316 |
|
| 2018 |
Zacharias N, Lee J, Ramachandran S, Shanmugavelandy S, McHenry J, Dutta P, Millward S, Gammon S, Efstathiou E, Troncoso P, Frigo DE, Piwnica-Worms D, Logothetis CJ, Maity SN, Titus MA, et al. Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In Vivo. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 29748904 DOI: 10.1007/S11307-018-1199-6 |
0.318 |
|
| 2018 |
Soundararajan R, Aparicio AM, Logothetis CJ, Mani SA, Maity SN. Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers. Frontiers in Oncology. 8: 69. PMID 29600194 DOI: 10.3389/Fonc.2018.00069 |
0.306 |
|
| 2018 |
Soundararajan R, Paranjape A, Joseph R, Bhangre N, Aparicio A, Maity S, Logothetis C, Chang J, Mani S. Abstract A065: Modulating a cancer stem cell-specific signaling pathway to reverse the course of neuroendocrine prostate cancer Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A065 |
0.34 |
|
| 2017 |
Karanika S, Karantanos T, Li L, Wang J, Park S, Yang G, Zuo X, Song JH, Maity SN, Manyam GC, Broom B, Aparicio AM, Gallick GE, Troncoso P, Corn PG, et al. Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling. Cell Reports. 18: 1970-1981. PMID 28228262 DOI: 10.1016/J.Celrep.2017.01.072 |
0.361 |
|
| 2016 |
Kleb B, Estécio MR, Zhang J, Tzelepi V, Chung W, Jelinek J, Navone NM, Tahir S, Marquez VE, Issa JP, Maity S, Aparicio A. Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas. Epigenetics. 0. PMID 26890396 DOI: 10.1080/15592294.2016.1146851 |
0.362 |
|
| 2016 |
Paranjape AN, Soundararajan R, Werden SJ, Joseph R, Taube JH, Liu H, Rodriguez-Canales J, Sphyris N, Wistuba I, Miura N, Dhillon J, Mahajan N, Mahajan K, Chang JT, Ittmann M, ... Maity SN, et al. Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties. Oncogene. PMID 26804168 DOI: 10.1038/Onc.2015.498 |
0.337 |
|
| 2015 |
Shi Z, Chiang CI, Labhart P, Zhao Y, Yang J, Mistretta TA, Henning SJ, Maity SN, Mori-Akiyama Y. Context-specific role of SOX9 in NF-Y mediated gene regulation in colorectal cancer cells. Nucleic Acids Research. 43: 6257-69. PMID 26040697 DOI: 10.1093/Nar/Gkv568 |
0.499 |
|
| 2015 |
Lee YC, Gajdosik MS, Josic D, Clifton JG, Logothetis C, Yu-Lee LY, Gallick GE, Maity SN, Lin SH. Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment. Molecular & Cellular Proteomics : McP. 14: 471-83. PMID 25527621 DOI: 10.1074/Mcp.M114.039909 |
0.329 |
|
| 2015 |
Maity SN, Wu G, Lu J, Hoang A, Landesman Y, McCauley D, Carlson R, Rashal T, Shacham S, Broom BM, Baggerly KA, Aparicio A, Efstathiou E, Araujo JC, Logothetis C. Effect of selinexor (KPT-330), a novel oral selective inhibitor of nuclear export (SINE), on tumor suppressors and cell cycle proteins in prostate cancer cells and regression of castration-resistant patient-derived xenograft tumor growth. Journal of Clinical Oncology. 33: 277-277. DOI: 10.1200/Jco.2015.33.7_Suppl.277 |
0.365 |
|
| 2015 |
Aparicio A, Shen L, Tapia ELN, Lu J, Chen H, Zhang J, Wu G, Wang X, Troncoso P, Broom BM, Baggerly KA, Logothetis C, Maity SN. A comprehensive molecular characterization of aggressive variant prostate cancer (PC). Journal of Clinical Oncology. 33: 149-149. DOI: 10.1200/Jco.2015.33.7_Suppl.149 |
0.338 |
|
| 2014 |
Mitani Y, Rao PH, Maity SN, Lee YC, Ferrarotto R, Post JC, Licitra L, Lippman SM, Kies MS, Weber RS, Caulin C, Lin SH, El-Naggar AK. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6570-81. PMID 25316813 DOI: 10.1158/1078-0432.Ccr-14-1746 |
0.349 |
|
| 2014 |
Li L, Chang W, Yang G, Ren C, Park S, Karantanos T, Karanika S, Wang J, Yin J, Shah PK, Takahiro H, Dobashi M, Zhang W, Efstathiou E, Maity SN, et al. Targeting poly(ADP-ribose) polymerase and the c-Myb-regulated DNA damage response pathway in castration-resistant prostate cancer. Science Signaling. 7: ra47. PMID 24847116 DOI: 10.1126/Scisignal.2005070 |
0.385 |
|
| 2014 |
Yamanaka T, Tosaki A, Kurosawa M, Matsumoto G, Koike M, Uchiyama Y, Maity SN, Shimogori T, Hattori N, Nukina N. NF-Y inactivation causes atypical neurodegeneration characterized by ubiquitin and p62 accumulation and endoplasmic reticulum disorganization. Nature Communications. 5: 3354. PMID 24566496 DOI: 10.1038/Ncomms4354 |
0.345 |
|
| 2014 |
Maity SN, Wu G, Lu J, Hoang A, Landesman Y, McCauley D, Shacham S, Kauffman MG, Aparicio AM, Efstathiou E, Araujo JC, Logothetis CJ. Abstract 3808: Preclinical efficacy of the novel, oral Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) on castration resistant prostate cancer Cancer Research. 74: 3808-3808. DOI: 10.1158/1538-7445.Am2014-3808 |
0.353 |
|
| 2013 |
Efstathiou E, Karlou M, Wen S, Hoang A, Pettaway CA, Pisters LL, Maity S, Troncoso P, Logothetis CJ. Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers. The Prostate. 73: 153-61. PMID 22753310 DOI: 10.1002/Pros.22550 |
0.303 |
|
| 2013 |
Maity SN, Wu G, Lu J, Eisner JR, Rafferty SW, Schotzinger RJ, Moore WR, Logothetis CJ, Araujo JC, Efstathiou E. Abstract 4772: Efficacy of VT-464, a novel selective inhibitor of cytochrome P450 17,20-lyase, in castrate-resistant prostate cancer models. Cancer Research. 73: 4772-4772. DOI: 10.1158/1538-7445.Am2013-4772 |
0.343 |
|
| 2013 |
Kleb BN, Estecio MR, Wu G, Lu J, Logothetis CJ, Maity S, Aparicio AM. Abstract 2986: Mechanism of androgen receptor (AR) silencing in small cell prostate carcinoma. Cancer Research. 73: 2986-2986. DOI: 10.1158/1538-7445.Am2013-2986 |
0.383 |
|
| 2013 |
Aparicio AM, Gallichotte E, Cheng H, Yoo S, Maity S, Logothetis C, Tewari M. Abstract 1205: Circulating micro-RNAs can detect adaptive response to therapy and aggressive subset of prostate cancer. Cancer Research. 73: 1205-1205. DOI: 10.1158/1538-7445.Am2013-1205 |
0.313 |
|
| 2013 |
Aparicio AM, Maity S, Wang X, Hoang AG, Efstathiou E, Troncoso P, Logothetis CJ. Abstract 1195: A molecular characterization of the anaplastic prostate carcinomas. Cancer Research. 73: 1195-1195. DOI: 10.1158/1538-7445.Am2013-1195 |
0.323 |
|
| 2012 |
Dayyani F, Parikh NU, Varkaris AS, Song JH, Moorthy S, Chatterji T, Maity SN, Wolfe AR, Carboni JM, Gottardis MM, Logothetis CJ, Gallick GE. Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways. Plos One. 7: e51189. PMID 23300537 DOI: 10.1371/Journal.Pone.0051189 |
0.312 |
|
| 2012 |
Kleb BN, Estecio M, Zhang J, Tzelepi V, Chung W, Maity S, Logothetis C, Troncoso P, Navone N, Jelinek J, Liang S, Issa J, Aparicio A. Abstract 991: The DNA methylome of castration-resistant prostate cancer Cancer Research. 72: 991-991. DOI: 10.1158/1538-7445.Am2012-991 |
0.344 |
|
| 2011 |
Luo R, Klumpp SA, Finegold MJ, Maity SN. Inactivation of CBF/NF-Y in postnatal liver causes hepatocellular degeneration, lipid deposition, and endoplasmic reticulum stress. Scientific Reports. 1: 136. PMID 22355653 DOI: 10.1038/Srep00136 |
0.394 |
|
| 2011 |
Li J, Ding Z, Wang Z, Lu JF, Maity SN, Navone NM, Logothetis CJ, Mills GB, Kim J. Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention. Plos One. 6: e28840. PMID 22194926 DOI: 10.1371/Journal.Pone.0028840 |
0.362 |
|
| 2011 |
Lee YC, Cheng CJ, Bilen MA, Lu JF, Satcher RL, Yu-Lee LY, Gallick GE, Maity SN, Lin SH. BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Research. 71: 5194-203. PMID 21670081 DOI: 10.1158/0008-5472.Can-10-4374 |
0.319 |
|
| 2011 |
Aparicio A, Tzelepi V, Araujo JC, Guo CC, Liang S, Troncoso P, Logothetis CJ, Navone NM, Maity SN. Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: morphological, immunohistochemical, and gene expression profiles. The Prostate. 71: 846-56. PMID 21456067 DOI: 10.1002/Pros.21301 |
0.329 |
|
| 2010 |
Gorlov IP, Sircar K, Zhao H, Maity SN, Navone NM, Gorlova OY, Troncoso P, Pettaway CA, Byun JY, Logothetis CJ. Prioritizing genes associated with prostate cancer development. Bmc Cancer. 10: 599. PMID 21044312 DOI: 10.1186/1471-2407-10-599 |
0.304 |
|
| 2010 |
Coustry F, Oh CD, Hattori T, Maity SN, de Crombrugghe B, Yasuda H. The dimerization domain of SOX9 is required for transcription activation of a chondrocyte-specific chromatin DNA template. Nucleic Acids Research. 38: 6018-28. PMID 20484372 DOI: 10.1093/Nar/Gkq417 |
0.651 |
|
| 2010 |
Oh CD, Maity SN, Lu JF, Zhang J, Liang S, Coustry F, de Crombrugghe B, Yasuda H. Identification of SOX9 interaction sites in the genome of chondrocytes. Plos One. 5: e10113. PMID 20404928 DOI: 10.1371/Journal.Pone.0010113 |
0.57 |
|
| 2010 |
Wan X, Yang J, Starbuck MW, Ravoori MK, Lu J, Kundra V, Maity S, Wang F, Navone NM. Abstract 344: Targeting fibroblast growth factor signaling in prostate cancer Cancer Research. 70: 344-344. DOI: 10.1158/1538-7445.Am10-344 |
0.303 |
|
| 2009 |
Karlou M, Tzelepi V, Maity S, Navone NM, Yang J, Lu J, Hoang A, Logothetis CJ, Efstathiou E. Abstract C253: Effective inhibition of Hedgehog signaling pathway with small molecule Smoothened inhibitor GDC‐0449 in a bone producing prostate cancer xenograft Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-C253 |
0.331 |
|
| 2008 |
Li ZG, Mathew P, Yang J, Starbuck MW, Zurita AJ, Liu J, Sikes C, Multani AS, Efstathiou E, Lopez A, Wang J, Fanning TV, Prieto VG, Kundra V, Vazquez ES, ... ... Maity S, et al. Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. The Journal of Clinical Investigation. 118: 2697-710. PMID 18618013 DOI: 10.1172/Jci33093 |
0.304 |
|
| 2008 |
Luo R, Lu JF, Hu Q, Maity SN. CBF/NF-Y controls endoplasmic reticulum stress induced transcription through recruitment of both ATF6(N) and TBP. Journal of Cellular Biochemistry. 104: 1708-23. PMID 18348279 DOI: 10.1002/Jcb.21736 |
0.753 |
|
| 2006 |
Hu Q, Lu JF, Luo R, Sen S, Maity SN. Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle. Nucleic Acids Research. 34: 6272-85. PMID 17098936 DOI: 10.1093/Nar/Gkl801 |
0.767 |
|
| 2004 |
Chattopadhyay C, Hawke D, Kobayashi R, Maity SN. Human p32, interacts with B subunit of the CCAAT-binding factor, CBF/NF-Y, and inhibits CBF-mediated transcription activation in vitro. Nucleic Acids Research. 32: 3632-41. PMID 15243141 DOI: 10.1093/Nar/Gkh692 |
0.47 |
|
| 2003 |
Bhattacharya A, Deng JM, Zhang Z, Behringer R, de Crombrugghe B, Maity SN. The B subunit of the CCAAT box binding transcription factor complex (CBF/NF-Y) is essential for early mouse development and cell proliferation. Cancer Research. 63: 8167-72. PMID 14678971 |
0.66 |
|
| 2002 |
Hu Q, Bhattacharya C, Maity SN. CCAAT binding factor (CBF) binding mediates cell cycle activation of topoisomerase IIalpha. Conventional CBF activation domains are not required. The Journal of Biological Chemistry. 277: 37191-200. PMID 12149265 DOI: 10.1074/Jbc.M205985200 |
0.776 |
|
| 2002 |
Li X, Bhattacharya C, Dayal S, Maity S, Klein WH. Ectoderm gene activation in sea urchin embryos mediated by the CCAAT-binding factor. Differentiation; Research in Biological Diversity. 70: 109-19. PMID 12076338 DOI: 10.1046/j.1432-0436.2002.700206.x |
0.406 |
|
| 2001 |
Coustry F, Hu Q, de Crombrugghe B, Maity SN. CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure. The Journal of Biological Chemistry. 276: 40621-30. PMID 11514576 DOI: 10.1074/Jbc.M106918200 |
0.794 |
|
| 2000 |
Zhu XS, Linhoff MW, Li G, Chin KC, Maity SN, Ting JP. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter. Molecular and Cellular Biology. 20: 6051-61. PMID 10913187 DOI: 10.1128/Mcb.20.16.6051-6061.2000 |
0.467 |
|
| 2000 |
Hu Q, Maity SN. Stable expression of a dominant negative mutant of CCAAT binding factor/NF-Y in mouse fibroblast cells resulting in retardation of cell growth and inhibition of transcription of various cellular genes. The Journal of Biological Chemistry. 275: 4435-44. PMID 10660616 DOI: 10.1074/Jbc.275.6.4435 |
0.777 |
|
| 1999 |
Faniello MC, Bevilacqua MA, Condorelli G, de Crombrugghe B, Maity SN, Avvedimento VE, Cimino F, Costanzo F. The B subunit of the CAAT-binding factor NFY binds the central segment of the Co-activator p300. The Journal of Biological Chemistry. 274: 7623-6. PMID 10075648 DOI: 10.1074/Jbc.274.12.7623 |
0.673 |
|
| 1998 |
Liang SG, Maity SN. Pathway of complex formation between DNA and three subunits of CBF/NF-Y. Photocross-linking analysis of DNA-protein interaction and characterization of equilibrium steps of subunit interaction and dna binding. The Journal of Biological Chemistry. 273: 31590-8. PMID 9813075 DOI: 10.1074/Jbc.273.47.31590 |
0.439 |
|
| 1998 |
Maity SN, de Crombrugghe B. Role of the CCAAT-binding protein CBF/NF-Y in transcription. Trends in Biochemical Sciences. 23: 174-8. PMID 9612081 DOI: 10.1016/S0968-0004(98)01201-8 |
0.676 |
|
| 1998 |
Coustry F, Sinha S, Maity SN, Crombrugghe B. The two activation domains of the CCAAT-binding factor CBF interact with the dTAFII110 component of the Drosophila TFIID complex. The Biochemical Journal. 291-7. PMID 9512492 DOI: 10.1042/Bj3310291 |
0.512 |
|
| 1997 |
Bi W, Wu L, Coustry F, de Crombrugghe B, Maity SN. DNA binding specificity of the CCAAT-binding factor CBF/NF-Y. The Journal of Biological Chemistry. 272: 26562-72. PMID 9334236 DOI: 10.1074/Jbc.272.42.26562 |
0.66 |
|
| 1997 |
Chen SS, Ruteshouser EC, Maity SN, de Crombrugghe B. Cell-specific in vivo DNA-protein interactions at the proximal promoters of the pro alpha 1(I) and the pro alpha2(I) collagen genes. Nucleic Acids Research. 25: 3261-8. PMID 9241239 DOI: 10.1093/Nar/25.16.3261 |
0.655 |
|
| 1996 |
Sinha S, Maity SN, Seldin MF, de Crombrugghe B. Chromosomal assignment and tissue expression of CBF-C/NFY-C, the third subunit of the mammalian CCAAT-binding factor. Genomics. 37: 260-3. PMID 8921405 DOI: 10.1006/Geno.1996.0555 |
0.609 |
|
| 1996 |
Maity SN, De Crombrugghe B. Purification, characterization, and role of CCAAT-binding factor in transcription. Methods in Enzymology. 273: 217-32. PMID 8791615 DOI: 10.1016/S0076-6879(96)73022-7 |
0.688 |
|
| 1996 |
Hasegawa T, Zhou X, Garrett LA, Ruteshouser EC, Maity SN, de Crombrugghe B. Evidence for three major transcription activation elements in the proximal mouse proalpha2(I) collagen promoter. Nucleic Acids Research. 24: 3253-60. PMID 8774909 |
0.653 |
|
| 1996 |
Lefebvre V, Zhou G, Mukhopadhyay K, Smith CN, Zhang Z, Eberspaecher H, Zhou X, Sinha S, Maity SN, de Crombrugghe B. An 18-base-pair sequence in the mouse proalpha1(II) collagen gene is sufficient for expression in cartilage and binds nuclear proteins that are selectively expressed in chondrocytes. Molecular and Cellular Biology. 16: 4512-23. PMID 8754852 |
0.608 |
|
| 1996 |
Kim IS, Sinha S, de Crombrugghe B, Maity SN. Determination of functional domains in the C subunit of the CCAAT-binding factor (CBF) necessary for formation of a CBF-DNA complex: CBF-B interacts simultaneously with both the CBF-A and CBF-C subunits to form a heterotrimeric CBF molecule. Molecular and Cellular Biology. 16: 4003-13. PMID 8754798 DOI: 10.1128/Mcb.16.8.4003 |
0.625 |
|
| 1996 |
Coustry F, Maity SN, Sinha S, de Crombrugghe B. The transcriptional activity of the CCAAT-binding factor CBF is mediated by two distinct activation domains, one in the CBF-B subunit and the other in the CBF-C subunit. The Journal of Biological Chemistry. 271: 14485-91. PMID 8662945 DOI: 10.1074/Jbc.271.24.14485 |
0.677 |
|
| 1996 |
Sinha S, Kim IS, Sohn KY, de Crombrugghe B, Maity SN. Three classes of mutations in the A subunit of the CCAAT-binding factor CBF delineate functional domains involved in the three-step assembly of the CBF-DNA complex. Molecular and Cellular Biology. 16: 328-37. PMID 8524312 DOI: 10.1128/Mcb.16.1.328 |
0.717 |
|
| 1996 |
Coustry F, Maity S, Sinha S, de Crombrugghe B. Dual mode of activation of transcription by CBF, a physiological activator of the two type I collagen genes Matrix Biology. 15: 192. DOI: 10.1016/S0945-053X(96)90092-X |
0.359 |
|
| 1996 |
Lefebvre V, Zhou G, Mukhopadhyay K, Smith CN, Zhang Z, Eberspaecher H, Zhou X, Sinha S, Maity SN, de Crombrugghe B. An 18-bp sequence in the mouse Proα1(II) collagen gene is sufficient for cartilage expression and binds nuclear proteins that are selectively expressed in chondrocytes Matrix Biology. 15: 192. DOI: 10.1016/S0945-053X(96)90091-8 |
0.393 |
|
| 1996 |
Bi W, Maity S, Coustry F, de Crombrugghe B. DNA binding specificity of CBF Matrix Biology. 15: 191. DOI: 10.1016/S0945-053X(96)90090-6 |
0.43 |
|
| 1995 |
Sinha S, Maity SN, Lu J, de Crombrugghe B. Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. Proceedings of the National Academy of Sciences of the United States of America. 92: 1624-8. PMID 7878029 DOI: 10.1073/Pnas.92.5.1624 |
0.637 |
|
| 1995 |
Coustry F, Maity SN, de Crombrugghe B. Studies on transcription activation by the multimeric CCAAT-binding factor CBF. The Journal of Biological Chemistry. 270: 468-75. PMID 7814413 DOI: 10.1074/Jbc.270.1.468 |
0.705 |
|
| 1994 |
Sohn KY, Maity SN, de Crombrugghe B. Studies on the structure of the mouse CBF-A gene and properties of a truncated CBF-A isoform generated from an alternatively spliced RNA. Gene. 139: 147-53. PMID 7509302 DOI: 10.1016/0378-1119(94)90748-X |
0.658 |
|
| 1994 |
Coustry F, Maity S, Fu S, de Crombrugghe B. Mechanisms for the Activation of transcrition by CBF, a physiological activator of the two type I collagen genes Matrix Biology. 14: 367-368. DOI: 10.1016/0945-053X(94)90066-3 |
0.319 |
|
| 1991 |
Crombrugghe Bd, Vuorio T, Karsenty G, Maity S, Rutheshouser EC, Goldberg H. Transcriptional control mechanisms for the expression of type I collagen genes. Annals of the Rheumatic Diseases. 50: 872-876. PMID 1750800 DOI: 10.1136/Ard.50.Suppl_4.872 |
0.366 |
|
| 1990 |
De Crombrugghe B, Karsenty G, Maity S, Vuorio T, Rossi P, Ruteshouser EC, McKinney SH, Lozano G. Transcriptional mechanisms controlling types I and III collagen genes. Annals of the New York Academy of Sciences. 580: 88-96. PMID 2337308 DOI: 10.1111/J.1749-6632.1990.Tb17921.X |
0.357 |
|
| 1990 |
Maity SN, Vuorio T, de Crombrugghe B. The B subunit of a rat heteromeric CCAAT-binding transcription factor shows a striking sequence identity with the yeast Hap2 transcription factor. Proceedings of the National Academy of Sciences of the United States of America. 87: 5378-82. PMID 2196566 DOI: 10.1073/Pnas.87.14.5378 |
0.652 |
|
| 1988 |
Maity SN, Golumbek PT, Karsenty G, de Crombrugghe B. Selective activation of transcription by a novel CCAAT binding factor. Science (New York, N.Y.). 241: 582-5. PMID 3399893 DOI: 10.1126/Science.3399893 |
0.688 |
|
| Show low-probability matches. |